Related results indicated Mn2+ treatment induced a significantly increased CD8+ and CD4+ TILs (tumor-infiltrating lymphocytes, TILs) in diverse tumor models to reduce tumor burdens. The gene discussed is CD8A; the disease is neoplasm.